Highest quality standards are achieved through the implementations of latest technology, decades of experience and everlasting moral values , which have helped us to retain our customers as well as multiply them.
JBCPL has had over 36 years of experience in manufacturing API’s. State-of-the art facilities conforming to USFDA as well as EU GMP guidelines, make JBCPL the leading partner for innovator and generic companies. An independent regulatory department prepares SOP’s, DMF technical packages and files CEP USDMF’s and EDMF’s. With a recently successful Korean FDA inspection, and a Certificate of Suitability for two products, the company is firmly on the global map.
JBCPL manufactures the following APIs
Atenolol USP (U.S. DMF NO. 024024
Cilnidipine
Diclofenac Acid (U.S. DMF NO. 15366)
Diclofenac Diethylamine BP/EP (U.S. DMF NO. 19020 & Spain DMF NO. DD-708/01)
Diclofenac Potassium BP/EP/USP (Plant approved by USFDA – U.S. DMF NO. 15074)
Diclofenac Sodium BP/EP/USP (U.S. DMF NO. 12469, Spain DMF NO. DS-092/978, Canadian DMF NO. 2005-055, Certificate of Suitability NO. R1-CEP-1997-41 REVISION 03)
Diclofenac Sodium BP/EP/USP (Injectable grade)
Nifedipine BP/EP/USP (U.S. DMF NO. 16730, Certificate of Suitability NO R1-CEP 2000-096-REV.03)
Gadopentatic acid
* To embrace new technologies and methods. * To give unsurpassed products and services to the clients. * To constantly look for improvement and changes.